- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
-
- 长期趋势：
已有367家主力机构披露2024-06-30报告期持股数据，持仓量总计3.33亿股，占流通A股59.85%
- 波段诊断：
-
技术面诊股
诊断结果：4.2技术面打败了65%的股票
技术面评分前10的股票
近期的平均成本为26.31元。
平均成本
近期的平均成本为26.31元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"26.31","date":1733387417,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2024.12.06","stock":"2.36","trade":"1.03","ind":"1.05"},{"date":"2024.12.05","stock":"-1.98","trade":"-0.04","ind":"0.13"},{"date":"2024.12.04","stock":"-0.34","trade":"-1.50","ind":"-0.42"},{"date":"2024.12.03","stock":"1.27","trade":"-0.14","ind":"0.44"},{"date":"2024.12.02","stock":"1.80","trade":"1.98","ind":"1.13"},{"date":"2024.11.29","stock":"0.23","trade":"0.60","ind":"0.93"},{"date":"2024.11.28","stock":"2.00","trade":"0.02","ind":"-0.43"},{"date":"2024.11.27","stock":"1.33","trade":"1.16","ind":"1.53"},{"date":"2024.11.26","stock":"-0.80","trade":"0.79","ind":"-0.12"},{"date":"2024.11.25","stock":"1.34","trade":"1.13","ind":"-0.10"},{"date":"2024.11.22","stock":"-4.50","trade":"-3.81","ind":"-3.06"},{"date":"2024.11.21","stock":"-1.45","trade":"0.44","ind":"0.07"},{"date":"2024.11.20","stock":"1.20","trade":"1.98","ind":"0.66"},{"date":"2024.11.19","stock":"1.06","trade":"1.11","ind":"0.67"},{"date":"2024.11.18","stock":"-2.78","trade":"-1.71","ind":"-0.21"},{"date":"2024.11.15","stock":"-2.67","trade":"-2.21","ind":"-1.45"},{"date":"2024.11.14","stock":"-3.02","trade":"-2.33","ind":"-1.73"},{"date":"2024.11.13","stock":"-2.35","trade":"-1.37","ind":"0.51"},{"date":"2024.11.12","stock":"-0.14","trade":"1.95","ind":"-1.39"},{"date":"2024.11.11","stock":"2.00","trade":"0.61","ind":"0.51"},{"date":"2024.11.08","stock":"-2.44","trade":"-0.12","ind":"-0.53"}]
太极集团,上证指数,中药指数
压力支撑
该股压力位为26.07元，支撑位为25.47元。
[{"text":"\u538b\u529b\u4f4d","value":"26.07","date":1733414400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"25.47","date":1733414400,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.9资金面打败了58%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体无进出。
更新时间：12月06日 20:30
| 机构今日流向(万元) | 1958.48 | 机构5日流向(万元) | -796.47 |
| 机构10日流向(万元) | -1021.79 | 机构20日流向(万元) | -19990.35 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少5908.92万股，其中基金净减仓17家，主力净减仓237家，请投资者中长期谨慎为宜。
截止2024-06-30，共367家主力机构（基金360家，保险公司2家，一般法人5家），持仓量总计33327.27万股，占流通A股59.85%
其中，基金持仓与2023-12-31相比：
增仓：70家 ，增持 1009.93万股
减仓：87家 ，减持 2892.83万股
新出现在主力名单中：192家 ，持有6337.19万股
从主力名单中消失：429家 ，原持有10052.32万股
其中，基金持仓与2023-12-31相比：
增仓：70家 ，增持 1009.93万股
减仓：87家 ，减持 2892.83万股
新出现在主力名单中：192家 ，持有6337.19万股
从主力名单中消失：429家 ，原持有10052.32万股
消息面诊股
诊断结果：5.5消息面打败了53%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 太极集团：公司产品太极藿香正气口服液入选国家卫健委
2024-12-06 - 太极集团：12月5日融券卖出金额10.84万元
2024-12-06 - 太极集团：葡萄糖酸钙注射液通过仿制药质量和疗效一致
2024-12-05 - 太极集团：12月4日融券卖出金额46.59万元，占
2024-12-05 - 太极集团两个项目荣获国药集团科技成果奖
2024-12-04 - 太极集团：12月3日获融资买入2269.87万元，
2024-12-04 - 国药太极西南药业硫酸阿托品注射液获一致性评价批件，
2024-12-03 - 太极集团：12月2日获融资买入2404.31万元，
2024-12-03 - 太极集团：公司严格按照《上海证券交易所股票上市规则
2024-12-02 - 太极集团：11月29日获融资买入2438.24万元
2024-12-02
消息列表
| 一般消息 | 募资投向 | 公司出售资产 | 2024-11-15 |
| 一般消息 | 高管变动 | 不再担任 | 2024-10-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-09-27 |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-09-05 |
| 一般消息 | 募资投向 | 预测年新增净利润为:22173.... | 2024-08-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-23 |
| 一般消息 | 重大事项 | 关联交易 | 2024-08-23 |
| 一般消息 | 高管变动 | 因达法定退休年龄 | 2024-06-27 |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-06-15 |
| 一般消息 | 重大事项 | 关联交易 | 2024-05-17 |
| 一般消息 | 股东大会 | 年度股东大会 | 2024-03-29 |
| 利好 | 分红转增 | 10派3元(含税) | 2024-03-29 |
| 一般消息 | 重大事项 | 关联交易 | 2024-03-29 |
| 一般消息 | 高管变动 | 因工作调动原因 | 2024-03-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-03-16 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2024-01-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-01-23 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 1条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.0行业面打败了73%的股票
中药行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2024.12.06","price":"1.05","value":"1.03"},{"date":"2024.12.05","price":"0.13","value":"-0.04"},{"date":"2024.12.04","price":"-0.42","value":"-1.50"},{"date":"2024.12.03","price":"0.44","value":"-0.14"},{"date":"2024.12.02","price":"1.13","value":"1.98"},{"date":"2024.11.29","price":"0.93","value":"0.60"},{"date":"2024.11.28","price":"-0.43","value":"0.02"},{"date":"2024.11.27","price":"1.53","value":"1.16"},{"date":"2024.11.26","price":"-0.12","value":"0.79"},{"date":"2024.11.25","price":"-0.10","value":"1.13"},{"date":"2024.11.22","price":"-3.06","value":"-3.81"},{"date":"2024.11.21","price":"0.07","value":"0.44"},{"date":"2024.11.20","price":"0.66","value":"1.98"},{"date":"2024.11.19","price":"0.67","value":"1.11"},{"date":"2024.11.18","price":"-0.21","value":"-1.71"},{"date":"2024.11.15","price":"-1.45","value":"-2.21"},{"date":"2024.11.14","price":"-1.73","value":"-2.33"},{"date":"2024.11.13","price":"0.51","value":"-1.37"},{"date":"2024.11.12","price":"-1.39","value":"1.95"},{"date":"2024.11.11","price":"0.51","value":"0.61"},{"date":"2024.11.08","price":"-0.53","value":"-0.12"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 葫芦娃 | 48.22% | 7.83% | 4.8分 |
| 2 | 嘉应制药 | 18.71% | 2.27% | 3.9分 |
| 3 | 万邦德 | 11.97% | 3.31% | 5.6分 |
| 4 | 粤万年青 | 10.83% | 3.09% | 4.0分 |
| 5 | 信邦制药 | 10.67% | 7.24% | 5.9分 |
| 6 | 佛慈制药 | 9.03% | 1.44% | 4.9分 |
| 8 | 金花股份 | 6.59% | -2.28% | 4.6分 |
| 10 | 益盛药业 | 5.75% | 2.80% | 4.8分 |
| 12 | 康惠制药 | 5.47% | -2.22% | 3.7分 |
| 14 | 康美药业 | 4.28% | 10.74% | 5.4分 |
| 16 | 益佰制药 | 2.69% | 5.26% | 5.0分 |
| 18 | *ST龙津 | 2.21% | 9.45% | 4.4分 |
| 20 | ST九芝 | 1.98% | 1.18% | 4.7分 |
| 22 | 华神科技 | 1.56% | 6.06% | 5.2分 |
| 24 | 吉林敖东 | 0.86% | 1.47% | 4.4分 |
| 26 | 新光药业 | 0.33% | 2.11% | 4.7分 |
| 28 | 仁和药业 | 0.17% | 1.01% | 4.5分 |
| 30 | 寿仙谷 | -1.04% | 2.84% | 4.4分 |
| 32 | 康恩贝 | -1.22% | 1.89% | 5.4分 |
| 34 | 启迪药业 | -1.67% | 6.31% | 4.1分 |
| 36 | 贵州三力 | -2.02% | -1.33% | 4.7分 |
| 38 | 华森制药 | -2.11% | -0.64% | 5.3分 |
| 40 | 上海凯宝 | -2.16% | 2.10% | 5.3分 |
| 42 | 白云山 | -2.40% | -0.52% | 5.0分 |
| 44 | 桂林三金 | -2.47% | -1.68% | 5.2分 |
| 46 | 羚锐制药 | -2.71% | 1.69% | 5.8分 |
| 48 | 云南白药 | -2.98% | 0.56% | 5.9分 |
| 50 | 陇神戎发 | -3.21% | 3.54% | 5.2分 |
| 52 | 江中药业 | -4.26% | 2.60% | 5.2分 |
| 54 | 同仁堂 | -4.87% | -0.37% | 4.3分 |
| 56 | 健民集团 | -5.42% | 0.49% | 4.7分 |
| 58 | 新天药业 | -5.54% | 2.13% | 5.2分 |
| 60 | 广誉远 | -5.98% | 2.64% | 4.8分 |
| 62 | 华润三九 | -6.39% | -0.69% | 5.5分 |
| 64 | 康缘药业 | -7.60% | 3.93% | 5.2分 |
| 66 | 济川药业 | -9.22% | -1.01% | 4.7分 |
| 68 | *ST大药 | -10.08% | 1.58% | 4.8分 |
| 70 | 香雪制药 | -13.44% | 0.49% | 4.3分 |
| 72 | *ST吉药 | -36.33% | -16.23% | 3.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/117 ， 51/117。
[{"date":"2024-09-30","value":"14.30","vol":"3.01"},{"date":"2024-06-30","value":"13.06","vol":"1.51"},{"date":"2024-03-31","value":"6.59","vol":"1.57"},{"date":"2023-12-31","value":"24.59","vol":"1.32"},{"date":"2023-09-30","value":"22.05","vol":"-36.03"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
14.30 | 13.06 | 6.59 | 24.59 | 22.05 |
| 行业(%) | 3.01 | 1.51 | 1.57 | 1.32 | -36.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"42.30","vol":"52.26"},{"date":"2024-06-30","value":"46.71","vol":"52.53"},{"date":"2024-03-31","value":"46.47","vol":"52.91"},{"date":"2023-12-31","value":"48.60","vol":"53.66"},{"date":"2023-09-30","value":"48.99","vol":"54.60"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
42.30 | 46.71 | 46.47 | 48.60 | 48.99 |
| 行业(%) | 52.26 | 52.53 | 52.91 | 53.66 | 54.60 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 54/117 ， 43/117。
[{"date":"2024-09-30","value":"-14.36","vol":"-4.89"},{"date":"2024-06-30","value":"-13.64","vol":"-4.85"},{"date":"2024-03-31","value":"-4.96","vol":"-2.72"},{"date":"2023-12-31","value":"10.58","vol":"3.91"},{"date":"2023-09-30","value":"14.58","vol":"6.61"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-14.36 | -13.64 | -4.96 | 10.58 | 14.58 |
| 行业(%) | -4.89 | -4.85 | -2.72 | 3.91 | 6.61 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-28.10","vol":"-1.06"},{"date":"2024-06-30","value":"-12.51","vol":"-20.25"},{"date":"2024-03-31","value":"5.05","vol":"-11.34"},{"date":"2023-12-31","value":"131.99","vol":"-18.78"},{"date":"2023-09-30","value":"197.57","vol":"9.62"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-28.10 | -12.51 | 5.05 | 131.99 | 197.57 |
| 行业(%) | -1.06 | -20.25 | -11.34 | -18.78 | 9.62 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/117 ， 17/117。
[{"date":"2024-09-30","value":"0.73","vol":"0.36"},{"date":"2024-06-30","value":"0.54","vol":"0.25"},{"date":"2024-03-31","value":"0.28","vol":"0.13"},{"date":"2023-12-31","value":"1.07","vol":"0.53"},{"date":"2023-09-30","value":"0.84","vol":"0.39"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.73 | 0.54 | 0.28 | 1.07 | 0.84 |
| 行业(次) | 0.36 | 0.25 | 0.13 | 0.53 | 0.39 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.13","vol":"1.77"},{"date":"2024-06-30","value":"1.44","vol":"1.21"},{"date":"2024-03-31","value":"0.79","vol":"0.65"},{"date":"2023-12-31","value":"3.30","vol":"2.83"},{"date":"2023-09-30","value":"2.55","vol":"2.04"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.13 | 1.44 | 0.79 | 3.30 | 2.55 |
| 行业(次) | 1.77 | 1.21 | 0.65 | 2.83 | 2.04 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"-12.73","vol":"5.27"},{"date":"2024-06-30","value":"-5.27","vol":"9.55"},{"date":"2024-03-31","value":"-3.97","vol":"0.64"},{"date":"2023-12-31","value":"33.37","vol":"19.92"},{"date":"2023-09-30","value":"-1.53","vol":"7.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -12.73 | -5.27 | -3.97 | 33.37 | -1.53 |
| 行业 | 5.27 | 9.55 | 0.64 | 19.92 | 7.50 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.69","vol":"1.34"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.82","vol":"1.43"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.69 | - | 1.82 | - |
| 行业 | 0.00 | 1.34 | 0.00 | 1.43 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 44/117 ， 31/117。
[{"date":"2024-09-30","value":"0.79","vol":"3.23"},{"date":"2024-06-30","value":"0.80","vol":"2.95"},{"date":"2024-03-31","value":"0.82","vol":"2.98"},{"date":"2023-12-31","value":"0.80","vol":"2.83"},{"date":"2023-09-30","value":"0.82","vol":"2.95"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.79 | 0.80 | 0.82 | 0.80 | 0.82 |
| 行业 | 3.23 | 2.95 | 2.98 | 2.83 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.43","vol":"2.43"},{"date":"2024-06-30","value":"0.45","vol":"2.24"},{"date":"2024-03-31","value":"0.49","vol":"2.29"},{"date":"2023-12-31","value":"0.48","vol":"2.15"},{"date":"2023-09-30","value":"0.48","vol":"2.23"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.43 | 0.45 | 0.49 | 0.48 | 0.48 |
| 行业 | 2.43 | 2.24 | 2.29 | 2.15 | 2.23 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 32/117 ， 4/117。
[{"date":"2024-09-30","value":"71.21","vol":"34.45"},{"date":"2024-06-30","value":"72.36","vol":"35.22"},{"date":"2024-03-31","value":"74.04","vol":"34.41"},{"date":"2023-12-31","value":"74.01","vol":"34.63"},{"date":"2023-09-30","value":"74.14","vol":"34.12"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
71.21 | 72.36 | 74.04 | 74.01 | 74.14 |
| 行业(%) | 34.45 | 35.22 | 34.41 | 34.63 | 34.12 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.55","vol":"3.07"},{"date":"2024-06-30","value":"2.70","vol":"1.58"},{"date":"2024-03-31","value":"2.94","vol":"0.95"},{"date":"2023-12-31","value":"2.94","vol":"0.86"},{"date":"2023-09-30","value":"2.78","vol":"0.59"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.55 | 2.70 | 2.94 | 2.94 | 2.78 |
| 行业(%) | 3.07 | 1.58 | 0.95 | 0.86 | 0.59 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2024-11-07 | 买入 | 买入 |
| 华福证券 | 2024-11-05 | 买入 | |
| 国泰君安 | 2024-11-04 | 买入 | |
| 光大证券 | 2024-11-04 | 买入 | 买入 |
| 东吴证券 | 2024-10-29 | 买入 | |
| 华创证券 | 2024-10-28 | 增持 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"0.66","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"-5.23","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.54","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.22","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.90","blueLineValue":"1.42","type":"YC"}]